First Time Loading...

HLS Therapeutics Inc
TSX:HLS

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
TSX:HLS
Watchlist
Price: 4.65 CAD Market Closed
Updated: May 3, 2024

HLS Therapeutics Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HLS Therapeutics Inc
Cash from Operating Activities Peer Comparison

Comparables:
M
MNX

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
HLS Therapeutics Inc
TSX:HLS
Cash from Operating Activities
$15.8m
CAGR 3-Years
19%
CAGR 5-Years
-14%
CAGR 10-Years
-2%
M
Manitex Capital Inc
XTSX:MNX
Cash from Operating Activities
-CA$298k
CAGR 3-Years
23%
CAGR 5-Years
29%
CAGR 10-Years
-16%

See Also

What is HLS Therapeutics Inc's Cash from Operating Activities?
Cash from Operating Activities
15.8m USD

Based on the financial report for Dec 31, 2023, HLS Therapeutics Inc's Cash from Operating Activities amounts to 15.8m USD.

What is HLS Therapeutics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-2%

Over the last year, the Cash from Operating Activities growth was -7%. The average annual Cash from Operating Activities growth rates for HLS Therapeutics Inc have been 19% over the past three years , -14% over the past five years , and -2% over the past ten years .